Satoshi Deyama

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Prefrontal Cortex

Vascular Endothelial Growth Factor

Neuropathic Pain

Top Venues

Nutritional neuroscience

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Translational psychiatry

Neuropsychopharmacology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Satoshi Deyama, Shun Aoki, Rinako Sugie, Hayato Fukuda, Satoshi Shuto, Masabumi Minami, Katsuyuki Kaneda
Intranasal Administration of Resolvin E1 Produces Antidepressant-Like Effects via BDNF/VEGF-mTORC1 Signaling in the Medial Prefrontal Cortex. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics (2023)
Satoshi Deyama, Rinako Sugie, Masaki Tabata, Katsuyuki Kaneda
Antidepressant-like effects of tomatidine and tomatine, steroidal alkaloids from unripe tomatoes, via activation of mTORC1 in the medial prefrontal cortex in lipopolysaccharide-induced depression model mice. Nutritional neuroscience (2023)
Satoshi Deyama, Xiao-Yuan Li, Ronald S Duman
Neuron-specific deletion of VEGF or its receptor Flk-1 occludes the antidepressant-like effects of desipramine and fluoxetine in mice. Neuropsychopharmacology reports (2023)
Satoshi Deyama, Makoto Kondo, Shoichi Shimada, Katsuyuki Kaneda
IGF-1 release in the medial prefrontal cortex mediates the rapid and sustained antidepressant-like actions of ketamine. Translational psychiatry 12 (1) (2022)